Table 3.
ME/CFS symptom characteristics
| Age of diagnosis (years [mean ± SEM]) | 29.6 ± 3.05 |
| Disease duration (years [mean ± SEM]) | 14.93 ± 3.17 |
| Infectious onset, n(%) | 13 (86.7%) |
| Cognitive difficulties | |
| Yes | 15 (100%) |
| No | 0 (0%) |
| Pain | |
| Yes | 15 (100%) |
| No | 0 (0%) |
| Sleep disturbances | |
| Yes | 15 (100%) |
| No | 0 (0%) |
| Sensory disturbances | |
| Yes | 15 (100%) |
| No | 0 (0%) |
| Immune disturbances | |
| Yes | 14 (93.3%) |
| No | 1 (6.7%) |
| Gastrointestinal disturbances | |
| Yes | 14 (93.3%) |
| No | 1 (6.7%) |
| Cardiovascular disturbances | |
| Yes | 15 (100%) |
| No | 0 (0%) |
| Respiratory disturbances | |
| Yes | 8 (53.3%) |
| No | 7 (46.7%) |
| Thermostatic instability | |
| Yes | 11 (73.3%) |
| No | 4 (26.7%) |
| Urinary disturbances | |
| Yes | 5 (33.3%) |
| No | 10 (66.7%) |
ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SEM standard error of mean, n number